Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses

Journal of Neuroscience

Volumn 29, Issue 47, 2009, Pages 14942-14955

  Wright, Megan C ^a   Potluri, Srilatha ^a   Wang, Xueyong ^b   Dentcheva, Eva ^a   Gautam, Dinesh ^c   Tessler, Alan ^a,d   Wess, Jürgen ^c   Rich, Mark M ^b   Son, Young Jin ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; ATROPINE; BOTULINUM TOXIN A; COMPLEMENTARY DNA; MESSENGER RNA; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; OTENZEPAD; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LASER CAPTURE MICRODISSECTION; MOUSE; MUSCLE DENERVATION; NERVE CELL PLASTICITY; NEUROMUSCULAR SYNAPSE; NEUROTRANSMISSION; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; REINNERVATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SYNAPTIC TRANSMISSION;

ANIMALS; ATROPINE; DENERVATION; DIAMINES; FEMALE; GROWTH CONES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR NEURONS; MUSCARINIC ANTAGONISTS; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; NERVE REGENERATION; NEUROMUSCULAR JUNCTION; NEURONAL PLASTICITY; PARALYSIS; PRESYNAPTIC TERMINALS; PROTEIN ISOFORMS; RECEPTORS, MUSCARINIC; WALLERIAN DEGENERATION;

EID: 72449135274     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2276-09.2009     Document Type: Article

References (91)

1. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ (2006) Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148:565-578. (Pubitemid 43993048)
2. Albani M, Lowrie MB, Vrbová G (1988) Reorganization of motor units in reinnervated muscles of the rat. J Neurol Sci 88:195-206. (Pubitemid 19016595)
3. Alexander SP, Mathie A, Peters JA (2008) Guide to receptors and channels (GRAC), Ed 3. Br J Pharmacol 153 [Suppl 2]:S1-S209.
4. Angaut-Petit D, Molgó J, Faille L, Juzans P, Takahashi M (1998) Incorporation of synaptotagmin II to the axolemma of botulinum type-A poisoned mouse motor endings during enhanced quantal acetylcholine release. Brain Res 797:357-360. (Pubitemid 28332752)
5. Argentieri TM, Aiken SP, Laxminarayan S, McArdle JJ (1992) Characteristics of synaptic transmission in reinnervating rat skeletal muscle. Pflugers Arch 421:256-261.
6. Balice-Gordon RJ, Lichtman JW (1990) In vivo visualization of the growth of pre- and postsynaptic elements of neuromuscular junctions in the mouse. J Neurosci 10:894-908.
7. Balice-Gordon RJ, Breedlove SM, Bernstein S, Lichtman JW (1990) Neuromuscular junctions shrink and expand as muscle fiber size is manipulated: in vivo observations in the androgen-sensitive bulbocavernosus muscle of mice. J Neurosci 10:2660-2671.
8. Brown MC, Ironton R (1978) Sprouting and regression of neuromuscular synapses in partially denervated mammalian muscles. J Physiol 278:325-348.
9. Burns AS, Jawaid S, Zhong H, Yoshihara H, Bhagat S, Murray M, Roy RR, Tessler A, Son YJ (2007) Paralysis elicited by spinal cord injury evokes selective disassembly of neuromuscular synapses with and without terminal sprouting in ankle flexors of the adult rat. J Comp Neurol 500:116-133. (Pubitemid 44904305)
10. Caulfield MP, Birdsall NJ (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279-290.
11. Das G (1989) Therapeutic review. Cardiac effects of atropine in man: an update. Int J Clin Pharmacol Ther Toxicol 27:473-477.
12. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727-733.
13. Eglen RM (2005) Muscarinic receptor subtype pharmacology and physiology. Prog Med Chem 43:105-136. (Pubitemid 40605496)
14. Feng Z, Ko CP (2007) Neuronal glia interactions at the vertebrate neuromuscular junction. Curr Opin Pharmacol 7:316-324. (Pubitemid 46731193)
15. Fisahn A, Yamada M, Duttaroy A, Gan JW, Deng CX, McBain CJ, Wess J (2002) Muscarinic induction of hippocampal gamma oscillations requires coupling of the M1 receptor to two mixed cation currents. Neuron 33:615-624. (Pubitemid 34188436)
16. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185:232-240. (Pubitemid 38084849)
17. Furlan I, Godinho RO (2005) Developing skeletal muscle cells express functional muscarinic acetylcholine receptors coupled to different intracellular signaling systems. Br J Pharmacol 146:389-396. (Pubitemid 41486681)
18. Garcia N, Santafé MM, Salon I, Lanuza MA, Tomàs J (2005) Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat. Histol Histopathol 20:733-743. (Pubitemid 40932591)
19. Gautam D, Duttaroy A, Cui Y, Han SJ, Deng C, Seeger T, Alzheimer C, Wess J (2006) M1-M3 muscarinic acetylcholine receptor-deficient mice: novel phenotypes. J Mol Neurosci 30:157-160. (Pubitemid 46035357)
20. Georgiou J, Robitaille R, Charlton MP (1999) Muscarinic control of cytoskeleton in perisynaptic glia. J Neurosci 19:3836-3846. (Pubitemid 29222260)
21. Glavinović MI (1979) Voltage clamping of unparalysed cut rat diaphragm for study of transmitter release. J Physiol 290:467-480.
22. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J (1999) Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 96:1692-1697. (Pubitemid 29098513)
23. Gomeza J, Zhang L, Kostenis E, Felder CC, Bymaster FP, Brodkin J, Shannon H, Xia B, Duttaroy A, Deng CX, Wess J (2001) Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice. Life Sci 68:2457-2466. (Pubitemid 32455682)
24. Hoffman H (1950) Local re-innervation in partially denervated muscle; a histophysiological study. Aust J Exp Biol Med Sci 28:383-397.
25. Jahromi BS, Robitaille R, Charlton MP (1992) Transmitter release increases intracellular calcium in perisynaptic Schwann cells in situ. Neuron 8:1069-1077.
26. Jordan T, Li J, Jiang H, DiMario JX (2003) Repression of slow myosin heavy chain 2 gene expression in fast skeletal muscle fibers by muscarinic acetylcholine receptor and G(alpha)q signaling. J Cell Biol 162:843-850. (Pubitemid 37087724)
27. Jositsch G, Papadakis T, Haberberger RV, Wolff M, Wess J, Kummer W (2009) Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor genedeficient mice. Naunyn Schmiedebergs Arch Pharmacol 379:389-395.
28. Juzans P, Comella JX, Molgo J, Faille L, Angaut-PetitD (1996) Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle. Neuromuscul Disord 6:177-185. (Pubitemid 26171260)
29. Ko CP, Chen L (1996) Synaptic remodeling revealed by repeated in vivo observations and electron microscopy of identified frog neuromuscular junctions. J Neurosci 16:1780-1790.
30. Kociolek LK, Bierig SM, Herrmann SC, Labovitz AJ (2006) Efficacy of atropine as a chronotropic agent in heart transplant patients undergoing dobutamine stress echocardiography. Echocardiography 23:383-387.
31. Koirala S, Qiang H, Ko CP (2000) Reciprocal interactions between perisynaptic Schwann cells and regenerating nerve terminals at the frog neuromuscular junction. J Neurobiol 44:343-360. (Pubitemid 30671623)
32. Kong L, Wang X, Choe DW, Polley M, Burnett BG, Bosch-Marcé M, Griffin JW, Rich MM, Sumner CJ (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci 29:842-851.
33. Kues WA, Brenner HR, Sakmann B, Witzemann V (1995) Local neurotrophic repression of gene transcripts encoding fetal AChRs at rat neuromuscular synapses. J Cell Biol 130:949-957.
34. Lamon S, Wallace MA, Léger B, Russell AP (2009) Regulation of STARS and its downstream targets suggest a novel pathway involved in human skeletal muscle hypertrophy and atrophy. J Physiol 587:1795-1803.
35. Langmead CJ, Watson J, Reavill C (2008) Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 117:232-243.
36. Lanuza MA, Garcia N, Santafe M, Nelson PG, Fenoll-Brunet MR, Tomas J (2001) Pertussis toxin-sensitive G-protein and protein kinase C activity are involved in normal synapse elimination in the neonatal rat muscle. J Neurosci Res 63:330-340. (Pubitemid 32115280)
37. Linseman DA, Hofmann F, Fisher SK (2000) A role for the small molecular weight GTPases, Rho and Cdc42, in muscarinic receptor signaling to focal adhesion kinase. J Neurochem 74:2010-2020. (Pubitemid 30217656)
38. Liu TP, Yu PC, Liu IM, Tzeng TF, Cheng JT (2002) Activation of muscarinic M1 receptors by acetylcholine to increase glucose uptake into cultured C2C12 cells. Auton Neurosci 96:113-118.
39. Love FM, Son YJ, ThompsonWJ (2003) Activity alters muscle reinnervation and terminal sprouting by reducing the number of Schwann cell pathways that grow to link synaptic sites. J Neurobiol 54:566-576.
40. Martin PT, Kaufman SJ, Kramer RH, Sanes JR (1996) Synaptic integrins in developing, adult, and mutant muscle: selective association of alpha1, alpha7A, and alpha7B integrins with the neuromuscular junction. Dev Biol 174:125-139. (Pubitemid 26098810)
41. Meunier FA, Schiavo G, Molgó J (2002) Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris 96:105-113. (Pubitemid 34087038)
42. Midrio M (2006) The denervated muscle: facts and hypotheses. A historical review. Eur J Appl Physiol 98:1-21.
43. Minic J, Molgó J, Karlsson E, Krejci E (2002) Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase. Eur J Neurosci 15:439-448. (Pubitemid 35463662)
44. Molinengo L, Fundarò A, Orsetti M (1989) The effect of chronic atropine administration on mouse motility and on ACh levels in the central nervous system. Pharmacol Biochem Behav 32:1075-1077. (Pubitemid 19210303)
45. Nathanson NM (2008) Synthesis, trafficking, and localization of muscarinic acetylcholine receptors. Pharmacol Ther 119:33-43.
46. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Grando SA (2003) Keratinocyte acetylcholine receptors regulate cell adhesion. Life Sci 72:2081-2085. (Pubitemid 36298951)
47. Patton BL, Chiu AY, Sanes JR (1998) Synaptic laminin prevents glial entry into the synaptic cleft. Nature 393:698-701.
48. Pawson C, Eaton BA, Davis GW (2008) Formin-dependent synaptic growth: evidence that Dlar signals via Diaphanous to modulate synaptic actin and dynamic pioneer microtubules. J Neurosci 28:11111-11123.
49. Pradidarcheep W, Labruyère WT, Dabhoiwala NF, Lamers WH (2008) Lack of specificity of commercially available antisera: better specifications needed. J Histochem Cytochem 56:1099-1111.
50. Prakash YS, Sieck GC (1998) Age-related remodeling of neuromuscular junctions on type-identified diaphragm fibers. Muscle Nerve 21:887-895.
51. Pun S, Sigrist M, Santos AF, Ruegg MA, Sanes JR, Jessell TM, Arber S, Caroni P (2002) An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles. Neuron 34:357-370. (Pubitemid 34465495)
52. Quigley RL, Shafer SH, Williams CL (1998) Regulation of integrin-mediated adhesion by muscarinic acetylcholine receptors and protein kinase C in small cell lung carcinoma. Chest 114:839-846.
53. Re L (1999) Modulation of acetylcholine release by presynaptic muscarinic autoreceptors. Acta Physiol Pharmacol Ther Latinoam 49:215-223.
54. Reinert A, Kaske A, Mense S (1998) Inflammation-induced increase in the density of neuropeptide-immunoreactive nerve endings in rat skeletal muscle. Exp Brain Res 121:174-180. (Pubitemid 28288875)
55. Reist NE, Smith SJ (1992) Neurally evoked calcium transients in terminal Schwann cells at the neuromuscular junction. Proc Natl Acad Sci U S A 89:7625-7629.
56. Renger JJ, Ueda A, Atwood HL, Govind CK, Wu CF (2000) Role of cAMP cascade in synaptic stability and plasticity: ultrastructural and physiological analyses of individual synaptic boutons in Drosophila memory mutants. J Neurosci 20:3980-3992.
57. Reyes R, Jaimovich E (1996) Functional muscarinic receptors in cultured skeletal muscle. Arch Biochem Biophys 331:41-47. (Pubitemid 26230617)
58. Reynolds ML, Woolf CJ (1992) Terminal Schwann cells elaborate extensive processes following denervation of the motor endplate. J Neurocytol 21:50-66.
59. 2+ responses resistant to muscarinic antagonists at perisynaptic Schwann cells of the frog neuromuscular junction. J Physiol 504:337-347.
60. Rochon D, Rousse I, Robitaille R (2001) Synapse-glia interactions at the mammalian neuromuscular junction. J Neurosci 21:3819-3829. (Pubitemid 32466474)
61. Rogozhin AA, Pang KK, Bukharaeva E, Young C, Slater CR (2008) Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A. J Physiol 586:3163-3182. (Pubitemid 351984697)
62. Santafé MM, Lanuza MA, Garcia N, Tomàs M, Tomàs J (2007) Coupling of presynaptic muscarinic autoreceptors to serine kinases in low and high release conditions on the rat motor nerve terminal. Neuroscience 148:432-440.
63. Schaefer AM, Sanes JR, Lichtman JW (2005) A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol 490:209-219. (Pubitemid 41140989)
64. Shafer SH, Puhl HL, Phelps SH, Williams CL (1999) Activation of transfected M1 or M3 muscarinic acetylcholine receptors induces cell-cell adhesion of Chinese hamster ovary cells expressing endogenous cadherins. Exp Cell Res 248:148-159.
65. Shi H, Scheffler JM, Zeng C, Pleitner JM, Hannon KM, Grant AL, Gerrard DE (2009) Mitogen-activated protein kinase signaling is necessary for the maintenance of skeletal muscle mass. Am J Physiol Cell Physiol 296: C1040-C1048.
66. Slutsky I, Wess J, Gomeza J, Dudel J, Parnas I, Parnas H (2003) Use of knockout mice reveals involvement of M2-muscarinic receptors in control of the kinetics of acetylcholine release. J Neurophysiol 89:1954-1967. (Pubitemid 36444251)
67. Son YJ, Scranton TW, Sunderland WJ, Baek SJ, Miner JH, Sanes JR, Carlson SS (2000) The synaptic vesicle protein SV2 is complexed with an alpha5-containing laminin on the nerve terminal surface. J Biol Chem 275: 451-460.
68. Son YJ, Thompson WJ (1995a) Nerve sprouting in muscle is induced and guided by processes extended by Schwann cells. Neuron 14:133-141.
69. Son YJ, Thompson WJ (1995b) Schwann cell processes guide regeneration of peripheral axons. Neuron 14:125-132.
70. Stengel PW, Yamada M, Wess J, Cohen ML (2002) M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol Regul Integr Comp Physiol 282: R1443-R1449. (Pubitemid 34664532)
71. Tam SL, Archibald V, Jassar B, Tyreman N, Gordon T (2001) Increased neuromuscular activity reduces sprouting in partially denervated muscles. J Neurosci 21:654-667. (Pubitemid 32107454)
72. Tawa NE Jr, Odessey R, Goldberg AL (1997) Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest 100:197-203. (Pubitemid 27311258)
73. Todd KJ, Auld DS, Robitaille R (2007) Neurotrophins modulate neuronglia interactions at a vertebrate synapse. Eur J Neurosci 25:1287-1296.
74. Triolo D, Dina G, Lorenzetti I, Malaguti M, Morana P, Del Carro U, Comi G, Messing A, Quattrini A, Previtali SC (2006) Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J Cell Sci 119:3981-3993. (Pubitemid 44650871)
75. Urazaev A, Naumenko N, Malomough A, Nikolsky E, Vyskocil F (2000) Carbachol and acetylcholine delay the early postdenervation depolarization of muscle fibres through M1-cholinergic receptors. Neurosci Res 37:255-263. (Pubitemid 30665469)
76. Urazaev AK, Naumenko NV, Poletayev GI, Nikolsky EE, Vyskocil F (1997) Acetylcholine and carbachol prevent muscle depolarization in denervated rat diaphragm. Neuroreport 8:403-406.
77. Verzè L, Buffo A, Rossi F, Oestreicher AB, Gispen WH, Strata P (1996) Increase of B-50/GAP-43 immunoreactivity in uninjured muscle nerves of MDX mice. Neuroscience 70:807-815. (Pubitemid 26009060)
78. Wang L, Yang L, Debidda M, Witte D, Zheng Y (2007) Cdc42 GTPase-activating protein deficiency promotes genomic instability and premature aging-like phenotypes. Proc Natl Acad Sci U S A 104:1248-1253. (Pubitemid 46183990)
79. Wang X, Engisch KL, Li Y, Pinter MJ, Cope TC, Rich MM (2004) Decreased synaptic activity shifts the calcium dependence of release at the mammalian neuromuscular junction in vivo. J Neurosci 24:10687-10692.
80. Wang X, Engisch KL, Teichert RW, Olivera BM, Pinter MJ, Rich MM (2006) Prolongation of evoked and spontaneous synaptic currents at the neuromuscular junction after activity blockade is caused by the upregulation of fetal acetylcholine receptors. J Neurosci 26:8983-8987. (Pubitemid 44319387)
81. Wang X, Li Y, Engisch KL, Nakanishi ST, Dodson SE, Miller GW, Cope TC, Pinter MJ, Rich MM (2005) Activity-dependent presynaptic regulation of quantal size at the mammalian neuromuscular junction in vivo. J Neurosci 25:343-351.
82. Welsh DG, Segal SS (1997) Coactivation of resistance vessels and muscle fibers with acetylcholine release from motor nerves. Am J Physiol 273:H156-H163. (Pubitemid 27347102)
83. Wess J (2004) Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 44:423-450.
84. Wess J, Eglen RM, Gautam D (2007) Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 6:721-733. (Pubitemid 47342315)
85. Wessler I (1989) Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptors. Trends Pharmacol Sci 10:110-114.
86. Weston CA, Teressa G, Weeks BS, Prives J (2007) Agrin and laminin induce acetylcholine receptor clustering by convergent, Rho GTPase-dependent signaling pathways. J Cell Sci 120:868-875. (Pubitemid 46523488)
87. Wright MC, Cho WJ, Son YJ (2007) Distinct patterns of motor nerve terminal sprouting induced by ciliary neurotrophic factor vs. botulinum toxin. J Comp Neurol 504:1-16.
88. Wright MC, Son YJ (2007) Ciliary neurotrophic factor is not required for terminal sprouting and compensatory reinnervation of neuromuscular synapses: re-evaluation of CNTF null mice. Exp Neurol 205:437-448.
89. Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Deng CX, Wess J (2001) Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410:207-212. (Pubitemid 32216592)
90. Yamada M, Basile AS, Fedorova I, Zhang W, Duttaroy A, Cui Y, Lamping KG, Faraci FM, Deng CX, Wess J (2003) Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology. Life Sci 74:345-353. (Pubitemid 37357065)
91. Yee WC, Pestronk A (1987) Mechanisms of postsynaptic plasticity: remodeling of the junctional acetylcholine receptor cluster induced by motor nerve terminal outgrowth. J Neurosci 7:2019-2024.